BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15919368)

  • 1. TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells.
    Chen A; Xu H; Choi Y; Wang B; Zheng G
    Cell Immunol; 2004; 231(1-2):40-8. PubMed ID: 15919368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.
    Josien R; Wong BR; Li HL; Steinman RM; Choi Y
    J Immunol; 1999 Mar; 162(5):2562-8. PubMed ID: 10072496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
    Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
    Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.
    Tsujimoto H; Uchida T; Efron PA; Scumpia PO; Verma A; Matsumoto T; Tschoeke SK; Ungaro RF; Ono S; Seki S; Clare-Salzler MJ; Baker HV; Mochizuki H; Ramphal R; Moldawer LL
    J Leukoc Biol; 2005 Oct; 78(4):888-97. PubMed ID: 16033815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL.
    Kim SH; Kim S; Oligino TJ; Robbins PD
    Mol Ther; 2002 Nov; 6(5):584-90. PubMed ID: 12409256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction.
    Cremer I; Dieu-Nosjean MC; Maréchal S; Dezutter-Dambuyant C; Goddard S; Adams D; Winter N; Menetrier-Caux C; Sautès-Fridman C; Fridman WH; Mueller CG
    Blood; 2002 Nov; 100(10):3646-55. PubMed ID: 12393586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.
    Huang J; Tatsumi T; Pizzoferrato E; Vujanovic N; Storkus WJ
    Cancer Res; 2005 Sep; 65(18):8461-70. PubMed ID: 16166326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of apoptosis-resistant T cell-activating dendritic cells promotes T helper type-2 response and IgE antibody production.
    Arques JL; Regoli M; Bertelli E; Nicoletti C
    Mol Immunol; 2008 Apr; 45(8):2177-86. PubMed ID: 18237782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes.
    Page G; Miossec P
    Arthritis Rheum; 2005 Aug; 52(8):2307-12. PubMed ID: 16052586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
    Buonocore S; Haddou NO; Moore F; Florquin S; Paulart F; Heirman C; Thielemans K; Goldman M; Flamand V
    J Leukoc Biol; 2008 Sep; 84(3):713-20. PubMed ID: 18567840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying dendritic cells via protein transfer for antitumor therapeutics.
    Liu S; Foster BA; Chen T; Zheng G; Chen A
    Clin Cancer Res; 2007 Jan; 13(1):283-91. PubMed ID: 17200367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen tension regulates the in vitro maturation of GM-CSF expanded murine bone marrow dendritic cells by modulating class II MHC expression.
    Goth SR; Chu RA; Pessah IN
    J Immunol Methods; 2006 Jan; 308(1-2):179-91. PubMed ID: 16406060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells.
    Bénard A; Boué J; Chapey E; Jaume M; Gomes B; Dietrich G
    J Neuroimmunol; 2008 Jun; 197(1):21-8. PubMed ID: 18486241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response.
    Ohta N; Ohashi Y; Fujino Y
    Anesth Analg; 2009 Sep; 109(3):793-800. PubMed ID: 19690248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.